
Inside the Invisible Forest: Can Gut Bacteria Predict Insulin Resistance?
New research suggests gut bacteria patterns may help predict insulin resistance in type 2 diabetes, offering potential for earlier risk detection and personalized care.

New research suggests gut bacteria patterns may help predict insulin resistance in type 2 diabetes, offering potential for earlier risk detection and personalized care.

A brain tumor diagnosis during pregnancy, though rare, can be a profound shock. Doctors say coordinated care and early evaluation of neurological symptoms are essential.

Researchers are developing universal vaccines that could offer broad protection against flu and other respiratory viruses, though large trials are still needed before availability.

Doctors say the most dangerous sign of low testosterone may be metabolic and cardiovascular changes, not reduced libido, highlighting the need for broader health evaluation.

Traumatic brain injury in New Zealand extends beyond sports and car crashes. Falls, subtle symptoms, and long recoveries challenge common myths and call for broader awareness.

Cardiac telehealth expanded rapidly across Australia and New Zealand during COVID-19. Experts say permanent adoption will require stable funding, infrastructure investment, clinical guidelines, and equity-focused policy reform.

Research shows childhood BMI changes may be genetically linked to higher risks of adult diabetes and heart disease, highlighting the importance of early prevention.

Experts warn that a growing shortage of neurologists could strain healthcare systems as demand rises, particularly with aging populations and increasing neurological conditions.

Research on zebrafish nerve regeneration offers new clues into chronic pain mechanisms, potentially guiding future treatments for persistent neuropathic conditions.

A new study finds IGF accelerates lymphatic vessel growth in experimental models, suggesting a possible future therapy for lymphedema pending further clinical research.

Officials in New Jersey are investigating clusters of dead and dying geese across parks, with bird flu suspected; the public is urged to avoid contact as monitoring continues.

New GLP-1 weight-loss medications show strong results but spark concerns about side effects, long-term safety, nutritional impacts, and unregulated use, reminding users of complexity beyond quick fixes.

State public-option health plans in Colorado, Washington, and Nevada are expanding but struggle to narrow coverage gaps as federal insurance subsidies expire and marketplace costs rise.

Residents of Hainesport Township are forced to dispose of dead birds amid a suspected outbreak, creating emotional and public health challenges. Uncertainty lingers as authorities investigate.

A new study shows that tiny network patterns, or motifs, can drive large-scale responses in complex systems, influencing cascades from power grids to disease outbreaks.

A large Danish study found that menopausal hormone therapy was not linked to increased mortality and may even lower death risk in specific surgical subgroups.

A new study finds the tropical chikungunya virus, spread by Aedes mosquitoes, can now be transmitted across much of Europe due to warmer temperatures and expanding mosquito ranges.

A new study finds that COVID-19 booster shots significantly reduce the risk of death, especially among older adults and high-risk groups, reinforcing the value of updated vaccination.

Research shows COVID-19 vaccination during pregnancy was associated with a reduced risk of preeclampsia, adding to evidence that maternal vaccination protects both mother and baby.

Bolivia has reported three deaths from Chikungunya fever and declared a red alert, intensifying mosquito control and public health measures to contain rising infections.

Advances in screening and targeted therapies have increased 10-year survival for certain metastatic breast cancer patients from about 20% to nearly 60%, marking significant progress in long-term care.

CEPI is seeking $2.5 billion to strengthen epidemic preparedness, supporting vaccine innovation and addressing emerging risks, including those linked to artificial intelligence.

The UK government is offering £20 million in grants to innovators developing new solutions for drug and alcohol addiction, aiming to improve prevention, treatment, and recovery outcomes nationwide.

A new federal funding opportunity supports innovative contracts in drug and alcohol addiction healthcare, aiming to expand access, improve outcomes, and strengthen recovery systems nationwide.